About

Dr. Kai-Jie Yu is a leading urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for kidney and prostate cancers, with a particular focus on optimizing oncologic outcomes and preserving quality of life. His major contributions include pioneering the use of indocyanine green fluorescence during robot-assisted partial nephrectomy to improve tumor resection precision, as demonstrated in his highly cited 2022 study (18 citations). Dr. Yu has also made significant strides in predicting and managing post-surgical complications, such as developing artificial intelligence models to forecast recovery from post-prostatectomy urinary incontinence (2023, 8 citations) and creating risk assessment tools for hemorrhagic events during partial nephrectomy. His research on 68Ga-PSMA-11 PET/CT imaging for detecting biochemically recurrent prostate cancer (2020, 16 citations) has advanced diagnostic accuracy in Taiwanese patients. With over 90 cumulative citations, Dr. Yu’s work has been instrumental in refining surgical techniques, improving patient selection, and enhancing functional outcomes, establishing him as a key figure in the field of minimally invasive urologic oncology.

Research Focus

Key Achievements

5
H-Index
10
Papers
91
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes
31 citations · 2018
📈 Most Prolific Year: 2024 (3 Papers)
🤝 Key Collaborators: 46
🏛 Institutions: The University of Texas MD Anderson Cancer Center, National Taipei University of Technology, Linkou Chang Gung Memorial Hospital, Chang Gung University, Chang Gung Memorial Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago